Are the Protective Effects of SGLT2 Inhibitors a "Class-Effect" or Are There Differences between Agents?

被引：14
|
作者：
Schmidt, Darren W. [1 ]
Argyropoulos, Christos [1 ]
Singh, Namita [1 ]
机构：
[1] Univ New Mexico, Sch Med, Div Nephrol, 1 Univ New Mexico,MSC04-2785, Albuquerque, NM 87131 USA
来源：
KIDNEY360 | 2021年 / 2卷 / 05期
关键词：
chronic kidney disease; class effects; clinical trials; heart failure; SGLT2; inhibitors; sodium glucose cotransporter two inhibitors; GLOMERULAR HYPERFILTRATION; HYPERGLYCEMIA;
D O I：
10.34067/KID.0000622021
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：881 / 885
页数：5
相关论文
共 50 条
  • [1] Kidney-Protective Effects of SGLT2 Inhibitors
    Palmer, Biff F.
    Clegg, Deborah J.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (02): : 279 - 289
  • [2] Cardiac and renal protective effects of SGLT2 inhibitors
    La, Lisa
    Maione, Luigi
    REVUE DE MEDECINE INTERNE, 2024, 45 (06): : 323 - 326
  • [3] Class effects of SGLT2 inhibitors on cardiorenal outcomes
    Kluger, Aaron Y.
    Tecson, Kristen M.
    Lee, Andy Y.
    Lerma, Edgar V.
    Rangaswami, Janani
    Lepor, Norman E.
    Cobble, Michael E.
    McCullough, Peter A.
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (01)
  • [4] Class effects of SGLT2 inhibitors on cardiorenal outcomes
    Aaron Y. Kluger
    Kristen M. Tecson
    Andy Y. Lee
    Edgar V. Lerma
    Janani Rangaswami
    Norman E. Lepor
    Michael E. Cobble
    Peter A. McCullough
    Cardiovascular Diabetology, 18
  • [5] SGLT2 inhibitors: glucosuria as an explanation for cardiorenal protective effects?
    Simon, Annika
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (02) : 100 - 101
  • [6] SGLT2 inhibitors: molecuar design and potential differences in effect
    Isaji, Masayuki
    KIDNEY INTERNATIONAL, 2011, 79 : S14 - S19
  • [7] SGLT2 Inhibitors as Potential Anticancer Agents
    Basak, Debasish
    Gamez, David
    Deb, Subrata
    BIOMEDICINES, 2023, 11 (07)
  • [8] Kidney protective mechanisms of SGLT2 inhibitors: evidence for a hemodynamic effect
    Yau, Kevin
    Cherney, David Z. I.
    van Raalte, Daniel H.
    Wever, Britt E.
    KIDNEY INTERNATIONAL, 2024, 105 (06) : 1168 - 1172
  • [9] Discovery of a new class of SGLT2 inhibitors
    Mascitti, Vincent
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [10] Multiple Effects of SGLT2 Inhibitors
    Nagasu, Hajime
    JMA JOURNAL, 2024, 7 (04): : 580 - 581
12345